FDA gives Prosensa's lead drug new path towards approval

June 3 (Reuters) - Prosensa Holding NV said the U.S. Food and Drug Administration had outlined a regulatory path for the accelerated approval of its lead drug.

from Reuters: Hot Stocks http://ift.tt/1pCkInS